Avingtrans Plc Adaptix appoints Willem Baralt as new Chairman

Avingtrans plc

Avingtrans PLC (LON:AVG) has announced that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies, will succeed Steve McQuillan (CEO of Avingtrans), who was appointed to the Board of Adaptix in December 2022 in an interim capacity. Steve will continue as a Non-Executive Director of Adaptix.

In 2021, Avingtrans plc invested £4m in Adaptix, for an 11.9% stake in the business and in December 2022 announced a further investment of £2m by means of a Convertible Loan Note.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Avingtrans Plc latest research note highlights progress and long-term opportunity from Cavendish

Cavendish’s latest research note on Avingtrans Plc points to a business with improving visibility, a strong position in specialist markets and a strategy that continues to build long-term value across its healthcare and industrial divisions.

Avingtrans delivers strong progress and upgraded outlook in latest Cavendish note

Cavendish has highlighted continued momentum at Avingtrans Plc, with the group’s latest trading update pointing to stronger performance, improved visibility and further progress across its specialist engineering businesses.

Avingtrans Plc latest research note highlights growth potential and strategic progress GMW

GMW’s latest research note on Avingtrans Plc highlights a business with strong long-term growth prospects, supported by a diversified industrial portfolio, improving market opportunities and continued strategic execution across its specialist engineering divisions.

Avingtrans Plc sees strong long-term growth potential in latest Cavendish note

Cavendish has highlighted Avingtrans Plc’s improving outlook, pointing to progress across its specialist engineering businesses, a supportive order backdrop and encouraging medium-term opportunities in aerospace, energy and medical markets.

Avingtrans Plc sees strong progress and margin improvement in latest Cavendish research note

Avingtrans Plc has been highlighted in a latest research note from Cavendish, with the broker pointing to continued operational progress, improved margins and a positive outlook across both of the group’s divisions. The note underlines the benefits of the company’s strategic focus on higher-quality earnings and disciplined execution.

Avingtrans Plc latest research note highlights progress and growth potential from Cavendish

Avingtrans Plc has been highlighted in the latest research note from Cavendish, with the broker pointing to continued progress across the group’s specialist engineering businesses and a positive outlook for the period ahead.

Search